Literature DB >> 11072234

p53-mediated negative regulation of stathmin/Op18 expression is associated with G(2)/M cell-cycle arrest.

J I Johnsen1, O N Aurelio, Z Kwaja, G E Jörgensen, N S Pellegata, R Plattner, E J Stanbridge, J F Cajot.   

Abstract

Utilizing the technique of differential display of mRNA, we have identified p53-responsive genes that are transcriptionally up- or down-regulated as cells enter growth arrest. One gene that was down-regulated, pong16, was found to be identical to stathmin/Op18, a protein involved in the regulation of microtubule dynamics. Evidence that p53 is directly or indirectly involved in negative regulation of stathmin/Op18 expression includes the following: (i) p53-mediated growth inhibition is associated with repression of stathmin/Op18 expression following serum stimulation, (ii) reporter gene assays revealed p53-mediated repression of stathmin/Op18 promoter activity and (iii) constitutive over-expression of stathmin/Op18 bypasses a p53-mediated G(2)/M arrest in the cell cycle. These results suggest that p53-mediated negative regulation of stathmin/Op18 plays an important role in cell-cycle control. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11072234     DOI: 10.1002/1097-0215(20001201)88:5<685::aid-ijc1>3.0.co;2-z

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  21 in total

1.  The microtubule cytoskeleton is required for a G2 cell cycle delay in cancer cells lacking stathmin and p53.

Authors:  Bruce K Carney; Victoria Caruso Silva; Lynne Cassimeris
Journal:  Cytoskeleton (Hoboken)       Date:  2012-03-29

Review 2.  Targeting the p53 pathway.

Authors:  Vita M Golubovskaya; William G Cance
Journal:  Surg Oncol Clin N Am       Date:  2013-07-30       Impact factor: 3.495

3.  Stathmin 1, a marker of PI3K pathway activation and regulator of microtubule dynamics, is expressed in early pelvic serous carcinomas.

Authors:  Alison M Karst; Keren Levanon; Sekhar Duraisamy; Joyce F Liu; Michelle S Hirsch; Jonathan L Hecht; Ronny Drapkin
Journal:  Gynecol Oncol       Date:  2011-06-17       Impact factor: 5.482

4.  p53-mediated heterochromatin reorganization regulates its cell fate decisions.

Authors:  Sathish Kumar Mungamuri; Erica Kay Benson; Shaomeng Wang; Wei Gu; Sam W Lee; Stuart A Aaronson
Journal:  Nat Struct Mol Biol       Date:  2012-04-01       Impact factor: 15.369

5.  MicroRNA-9 inhibits vasculogenic mimicry of glioma cell lines by suppressing Stathmin expression.

Authors:  Yuwen Song; Luyan Mu; Xuezhe Han; Qingla Li; Baijing Dong; Hulun Li; Xiaoqian Liu
Journal:  J Neurooncol       Date:  2013-09-17       Impact factor: 4.130

6.  Hedgehog signaling regulates proliferation of prostate cancer cells via stathmin1.

Authors:  Moon-Kee Chung; Hyun-Jung Kim; Young-Suk Lee; Myoung-Eun Han; Sik Yoon; Sun-Yong Baek; Bong-Seon Kim; Jae-Bong Kim; Sae-Ock Oh
Journal:  Clin Exp Med       Date:  2009-09-25       Impact factor: 3.984

7.  A cohort study of STMN1 expression in colorectal cancer: body mass index and prognosis.

Authors:  Shuji Ogino; Katsuhiko Nosho; Yoshifumi Baba; Shoko Kure; Kaori Shima; Natsumi Irahara; Saori Toyoda; Li Chen; Gregory J Kirkner; Brian M Wolpin; Andrew T Chan; Edward L Giovannucci; Charles S Fuchs
Journal:  Am J Gastroenterol       Date:  2009-06-09       Impact factor: 10.864

8.  Genomewide gene expression profiles of HPV-positive and HPV-negative oropharyngeal cancer: potential implications for treatment choices.

Authors:  Pawadee Lohavanichbutr; John Houck; Wenhong Fan; Bevan Yueh; Eduardo Mendez; Neal Futran; David R Doody; Melissa P Upton; D Gregory Farwell; Stephen M Schwartz; Lue Ping Zhao; Chu Chen
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2009-02

Review 9.  Focal adhesion kinase and p53 signal transduction pathways in cancer.

Authors:  Vita M Golubovskaya; William Cance
Journal:  Front Biosci (Landmark Ed)       Date:  2010-06-01

10.  Stathmin is dispensable for tumor onset in mice.

Authors:  Sara D'Andrea; Stefania Berton; Ilenia Segatto; Linda Fabris; Vincenzo Canzonieri; Alfonso Colombatti; Andrea Vecchione; Barbara Belletti; Gustavo Baldassarre
Journal:  PLoS One       Date:  2012-09-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.